Search results
Showing 811 to 825 of 1362 results for social care
NG74/2 Question Team composition for home-based intermediate care:- How effective and cost effective are different approaches, in terms...
positive' approach in care homes:- What is the effectiveness and acceptability of different strategies to enable positive risk-taking in...
Recommendation ID NG58/5 Question Care pathway:- In the UK, what is the optimal care pathway for young people and adults...
Upadacitinib for previously treated moderately to severely active Crohn's disease (TA905)
Evidence-based recommendations on upadacitinib (Rinvoq) for previously treated moderately to severely active Crohn’s disease in adults.
Ovarian cancer: identifying and managing familial and genetic risk (NG241)
This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults.
This guide outlines the main elements of the interim process and methods for the NICE clinical guideline updates using standing committees pilot programme, including details of the Clinical Guidelines Updates committee, which were agreed by the NICE Board in September 2013
role of primary care in supporting young people discharged from children's services:- What are the most effective ways for primary...
Carers:- In what context is it cost effective to increase uptake of flu vaccination among carers?
This key target group can be difficult to identify, and people who provide care may not always identify themselves as carers. The...
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Recommendation ID NG74/4 Question Dementia care:- How effective and cost effective is intermediate care including...
This guideline covers identifying and managing otitis media with effusion (OME), also known as ‘glue ear’, in children younger than 12 years. It aims to improve hearing and quality of life in children with OME.
research, see the rationale section on assessment and care by healthcare professionals and social care practitioners. Full...
Dupilumab for treating moderate to severe atopic dermatitis (TA534)
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests